PF-06939999

PF-06939999 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06939999, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors [Phase 1]